254 related articles for article (PubMed ID: 33041218)
21. Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus.
Yamada SD; Burger RA; Brewster WR; Anton D; Kohler MF; Monk BJ
Cancer; 2000 Jun; 88(12):2782-6. PubMed ID: 10870061
[TBL] [Abstract][Full Text] [Related]
22. Clinical significance of radiotherapy in patients with primary uterine carcinosarcoma: a multicenter retrospective study (KROG 13-08).
Cha J; Kim YS; Park W; Kim HJ; Kim JY; Kim JH; Kim J; Yoon WS; Kim JW; Kim YB
J Gynecol Oncol; 2016 Nov; 27(6):e58. PubMed ID: 27550404
[TBL] [Abstract][Full Text] [Related]
23. Significance of Lymphovascular Space Invasion by the Sarcomatous Component in Uterine Carcinosarcoma.
Matsuo K; Takazawa Y; Ross MS; Elishaev E; Yunokawa M; Sheridan TB; Bush SH; Klobocista MM; Blake EA; Takano T; Baba T; Satoh S; Shida M; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Yanai S; Takeuchi S; Nishimura M; Iwasaki K; Johnson MS; Yoshida M; Hakam A; Machida H; Mhawech-Fauceglia P; Ueda Y; Yoshino K; Kajiwara H; Hasegawa K; Yasuda M; Miyake TM; Moriya T; Yuba Y; Morgan T; Fukagawa T; Pejovic T; Nagano T; Sasaki T; Richmond AM; Post MD; Shahzad MMK; Im DD; Yoshida H; Enomoto T; Omatsu K; Ueland FR; Kelley JL; Karabakhtsian RG; Roman LD
Ann Surg Oncol; 2018 Sep; 25(9):2756-2766. PubMed ID: 29971677
[TBL] [Abstract][Full Text] [Related]
24. The Effect of Adjuvant Pelvic Radiotherapy on Distant Metastasis for Uterine Carcinosarcoma.
Eng NL; Rana SR; Hall KL; Eng TY
Am J Clin Oncol; 2021 Apr; 44(4):169-173. PubMed ID: 33481373
[TBL] [Abstract][Full Text] [Related]
25. Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.
Sozen H; Çiftçi R; Vatansever D; Topuz S; Iyibozkurt AC; Bozbey HU; Yaşa C; Çali H; Yavuz E; Kucucuk S; Aydiner A; Salihoglu Y
Aust N Z J Obstet Gynaecol; 2016 Apr; 56(2):199-206. PubMed ID: 26890292
[TBL] [Abstract][Full Text] [Related]
26. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study.
Sartori E; Bazzurini L; Gadducci A; Landoni F; Lissoni A; Maggino T; Zola P; La Face B
Gynecol Oncol; 1997 Oct; 67(1):70-5. PubMed ID: 9345359
[TBL] [Abstract][Full Text] [Related]
27. A multi-institutional study of outcomes in stage I-III uterine carcinosarcoma.
Dickson EL; Vogel RI; Gehrig PA; Pierce S; Havrilesky L; Secord AA; Dottino J; Fader AN; Ricci S; Geller MA
Gynecol Oncol; 2015 Nov; 139(2):275-82. PubMed ID: 26348313
[TBL] [Abstract][Full Text] [Related]
28. Prognostic factors and adjuvant therapy in uterine carcinosarcoma.
Wu TI; Hsu KH; Huang HJ; Hsueh S; Chou HH; Tsai CS; Ho KC; Chao A; Chang TC; Lai CH
Eur J Gynaecol Oncol; 2008; 29(5):483-8. PubMed ID: 19051818
[TBL] [Abstract][Full Text] [Related]
29. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
[TBL] [Abstract][Full Text] [Related]
30. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy.
Leath CA; Numnum TM; Kendrick JE; Frederick PJ; Rocconi RP; Conner MG; Straughn JM
Int J Gynecol Cancer; 2009 Jul; 19(5):888-91. PubMed ID: 19574779
[TBL] [Abstract][Full Text] [Related]
31. Prognostic factors and treatment outcomes in 93 patients with uterine sarcoma from 4 centers in Turkey.
Durnali A; Tokluoğlu S; Özdemir N; Inanç M; Alkiş N; Zengin N; Sönmez ÖU; Küçüköner M;
Asian Pac J Cancer Prev; 2012; 13(5):1935-41. PubMed ID: 22901150
[TBL] [Abstract][Full Text] [Related]
32. [Carcinosarcomas in female genital tracts: general review].
Guy JB; Trone JC; Casteillo F; Forest F; Pacaut C; Moncharmont C; Espenel S; Vallard A; Langrand Escure J; Collard O; Peoc'h M; Magné N
Bull Cancer; 2014; 101(7-8):760-4. PubMed ID: 25091658
[TBL] [Abstract][Full Text] [Related]
33. Uterine and ovary carcinosarcomas: outcome, prognosis factors, and adjuvant therapy.
Pacaut C; Bourmaud A; Rivoirard R; Moriceau G; Guy JB; Collard O; Bosacki C; Jacquin JP; Levy A; Chauleur C; Magné N; Merrouche Y
Am J Clin Oncol; 2015 Jun; 38(3):272-7. PubMed ID: 23751320
[TBL] [Abstract][Full Text] [Related]
34. Adjuvant radiotherapy improves overall survival when added to surgery and chemotherapy for uterine carcinosarcoma: a surveillance, epidemiology, and end results analysis.
Squires BS; Quinn TJ; Nandalur SR; Jawad MS
Int J Clin Oncol; 2021 Dec; 26(12):2282-2294. PubMed ID: 34427803
[TBL] [Abstract][Full Text] [Related]
35. How to deal with prognostic factors and radiotherapy results in uterine neoplasms with a sarcomatous component?
Rovirosa A; Ascaso C; Ordi J; Arenas M; Valduvieco I; Lejarcegui JA; Pahisa J; Torne A; Biete A
Clin Transl Oncol; 2009 Oct; 11(10):681-7. PubMed ID: 19828411
[TBL] [Abstract][Full Text] [Related]
36. Prognostic determinants in patients with uterine and ovarian carcinosarcoma.
Rauh-Hain JA; Shoni M; Schorge JO; Goodman A; Horowitz NS; del Carmen MG
J Reprod Med; 2013; 58(7-8):297-304. PubMed ID: 23947079
[TBL] [Abstract][Full Text] [Related]
37. Uterine carcinosarcoma: Contemporary clinical summary, molecular updates, and future research opportunity.
Matsuzaki S; Klar M; Matsuzaki S; Roman LD; Sood AK; Matsuo K
Gynecol Oncol; 2021 Feb; 160(2):586-601. PubMed ID: 33183764
[TBL] [Abstract][Full Text] [Related]
38. Significance of histologic pattern of carcinoma and sarcoma components on survival outcomes of uterine carcinosarcoma.
Matsuo K; Takazawa Y; Ross MS; Elishaev E; Podzielinski I; Yunokawa M; Sheridan TB; Bush SH; Klobocista MM; Blake EA; Takano T; Matsuzaki S; Baba T; Satoh S; Shida M; Nishikawa T; Ikeda Y; Adachi S; Yokoyama T; Takekuma M; Fujiwara K; Hazama Y; Kadogami D; Moffitt MN; Takeuchi S; Nishimura M; Iwasaki K; Ushioda N; Johnson MS; Yoshida M; Hakam A; Li SW; Richmond AM; Machida H; Mhawech-Fauceglia P; Ueda Y; Yoshino K; Yamaguchi K; Oishi T; Kajiwara H; Hasegawa K; Yasuda M; Kawana K; Suda K; Miyake TM; Moriya T; Yuba Y; Morgan T; Fukagawa T; Wakatsuki A; Sugiyama T; Pejovic T; Nagano T; Shimoya K; Andoh M; Shiki Y; Enomoto T; Sasaki T; Fujiwara K; Mikami M; Shimada M; Konishi I; Kimura T; Post MD; Shahzad MM; Im DD; Yoshida H; Omatsu K; Ueland FR; Kelley JL; Karabakhtsian RG; Roman LD
Ann Oncol; 2016 Jul; 27(7):1257-66. PubMed ID: 27052653
[TBL] [Abstract][Full Text] [Related]
39. Impact of multimodal therapy on the survival of patients with newly diagnosed uterine carcinosarcoma.
Machida H; Takahashi K; Nomura H; Matoda M; Omatsu K; Kato K; Umayahara K; Takeshima N
Eur J Gynaecol Oncol; 2013; 34(4):291-5. PubMed ID: 24020131
[TBL] [Abstract][Full Text] [Related]
40. Impact of adjuvant pelvic radiotherapy in stage I uterine sarcoma.
Magnuson WJ; Petereit DG; Anderson BM; Geye HM; Bradley KA
Anticancer Res; 2015 Jan; 35(1):365-70. PubMed ID: 25550573
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]